Leukemia inhibitory factor induces epidermal hyperplasia in patients with amyotrophic lateral sclerosis

Journal of Investigative Dermatology

Volumn 115, Issue 3, 2000, Pages 486-492

  Hu, Jianguo ^c   Ono, Seiitsu ^a   Katayama, Hiroyuki ^c   Imai, Takashi ^b   Shimizu, Natsue ^a   Nakagawa, Hachiro ^c  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Chiba Higashi Hospital   (Japan)

^c NONE

Author keywords

ALS; Bedsore; Epidermal hyperptasia; LIF

Indexed keywords

LEUKEMIA INHIBITORY FACTOR;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE CONTROL; EPIDERMIS HYPERPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; PRIORITY JOURNAL; SKIN DISEASE;

EID: 0033832702     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00047.x     Document Type: Article

References (31)

1. Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine
2. Effect of growth factors on cell proliferation and epithelialization in human skin
3. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormality, and spontaneous tumor formation in transgenic mice
4. Amyotrophic lateral sclerosis and bedsores
5. Leukemia inhibitory factor expression in human carotid plaques: Possible mechanism for inhibition of large vessel endothelial regrowth
6. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily
7. Expression of leukaemia inhibitory factor in skin of patients with amyotrophic lateral sclerosis
8. Leukemia inhibitor and interleukin-6 are produced by disease and regenerating skeletal muscle
9. The role of leukemia inhibitory factor in skeletal muscle regeneration
10. LIF (AM424), a promising growth factor for the treatment of ALS
11. Essential function of LIF receptor in motor neurons
12. Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures
13. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-beta
14. Sporadic ALS and chromosome 22: Evidence for a possible neurofilament gene defect
15. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
16. Collagen cross-linking of skin in patients with amyotrophic lateral sclerosis
17. Amyotrophic lateral sclerosis: Increased solubility of skin collagen
18. Glutamate and aspartate are decreased in the skin in amyotrophic lateral sclerosis
19. Amyotrophic lateral sclerosis: Histologic, histochernical, and ultrastructural abnormalities of skin
20. Increased dermal collagen density in amyotrophic lateral sclerosis
21. Amorphous material of skin in amyotrophic lateral sclerosis: A morphologic and biochemical study
22. Hyaluronic acid is increased in the skin and urine in patients with amyotrophic lateral sclerosis
23. Ciliary neurotrophic factor in skin biopsies of patients with amyotrophic lateral sclerosis
24. Decreased type IV collagen of skin and serum in patients with amyotrophic lateral sclerosis
25. Alterations of skin glycosaminoglycans in patients with ALS
26. Leukaemia inhibitory factor is expressed by normal human keratinocytes in vitro and in vivo
27. Leukaemia inhibitory factor or related factors promote the differentiation of neuronal and astrocytic precursors within the developing murine spinal cord
28. Current trends in pressure ulcer research
29. Pressure sores
30. The tripartite CNTF receptor complex: Activation and signaling involves components shared with other cytokines
31. Skin changes in patients with amyotrophic lateral sclerosis: Light and electron microscopic observatiom